Understanding Semaglutide and What It Does Semaglutide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists
Lemme GLP-1 Daily does not contain synthetic GLP-1 hormone and is not a GLP-1 agonist drug
Always introduce new supplements slowly and under supervision
What is cagrilintide and how does it differ from semaglutide Cagrilintide: Long-acting amylin analog What cagrilintide is: Synthetic analog of amylin (human hormone) Long-acting formulation (weekly dosing) Developed by Novo Nordisk Currently in Phase 3 clinical trials Not yet FDA approved (as of 2024) Paired with semaglutide as "CagriSema" How amylin works naturally: Co-secreted with insulin from pancreatic beta cells Released after meals Slows gastric emptying (food stays in stomach longer) Reduces glucagon secretion Signals satiety to brain Regulates postprandial glucose Cagrilintide's mechanisms: Mimics natural amylin but lasts much longer Dramatically slows gastric emptying Increases satiety and fullness Reduces food intake Lowers postprandial glucose Works on amylin receptors (different from GLP-1) Primary benefits: Powerful appetite suppression Extended feeling of fullness Reduced meal frequency Lower caloric intake Glucose regulation Complements GLP-1 action Learn about peptides , how peptides work , and what are peptides used for in our foundational guides
Since Danielle was considered obese, her doctor prescribed the semaglutide injection, Ozempic, off-label
In rare cases, dryness is compounded by another medication, and a small adjustment can solve it
